Teclistamab, Talquetamab, and Elranatamab: Response Rates and Data

Episodios

Advances in Thyroid Cancer Treatment
29 ago· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Drs. Patel, Sheth, and Weiss discuss emerging data and advances in thyroid cancer treatment.
- Escuchar Escuchar de nuevo Continuar Reproduciendo...
- Escuchar más tarde Escuchar más tarde
Incurable HPV Negative Head and Neck Cancer
21 ago· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Drs. Patel, Sheth, and Weiss discuss current treatment options and emerging data in incurable HPV negative head and neck cancer.
- Escuchar Escuchar de nuevo Continuar Reproduciendo...
- Escuchar más tarde Escuchar más tarde
¿Faltan episodios?

Pulsa aquí para actualizar resultados
Recurrent/Metastatic HPV Positive Head and Neck Cancer
14 ago· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Drs. Patel, Sheth, and Weiss discuss current treatment options and emerging data in recurrent/metastatic HPV positive head and neck cancer.
- Escuchar Escuchar de nuevo Continuar Reproduciendo...
- Escuchar más tarde Escuchar más tarde
Curable HPV Negative Head and Neck Cancer
7 ago· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Drs. Patel, Sheth, and Weiss discuss current treatment options and emerging data in curable HPV negative head and neck cancer.
- Escuchar Escuchar de nuevo Continuar Reproduciendo...
- Escuchar más tarde Escuchar más tarde
Curable HPV Positive Head and Neck Cancer
30 jul· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Drs. Patel, Sheth, and Weiss discuss current treatment options and emerging data in curable HPV positive head and neck cancer.
- Escuchar Escuchar de nuevo Continuar Reproduciendo...
- Escuchar más tarde Escuchar más tarde
What is a Bone Marrow Transplant?
12 jun· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Marco Ruiz explains the concept of bone marrow transplant, and how it is used in treating blood cancers.
- Escuchar Escuchar de nuevo Continuar Reproduciendo...
- Escuchar más tarde Escuchar más tarde
Q&A: Do People in Rural Communities Have Equal Access to Treatment Options?
10 jun· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Drs. Goodman, Phillips, Taneja, and Rajeeve discuss whether a patient's location can affect the treatments they can access and their overall prognosis.
- Escuchar Escuchar de nuevo Continuar Reproduciendo...
- Escuchar más tarde Escuchar más tarde
Q&A: Is my Clinical Trial Affecting my Body's Reaction to the Covid-19 Vaccine?
5 jun· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Drs. Goodman, Phillips, Taneja, and Rajeeve discuss how to navigate treatment and Covid vaccination.
- Escuchar Escuchar de nuevo Continuar Reproduciendo...
- Escuchar más tarde Escuchar más tarde
Bispecific Antibodies in Myeloma: Approvals and Clinical Trials
31 may· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Sridevi Rajeeve discusses current FDA approved bispecific antibodies and ones coming from clinical trials.
- Escuchar Escuchar de nuevo Continuar Reproduciendo...
- Escuchar más tarde Escuchar más tarde
Curative Strategies for Patients with Smoldering Multiple Myeloma
23 may· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Alankrita Taneja examines data from the CESAR trial, and discusses curative strategies for Smoldering Multiple Myeloma.
- Escuchar Escuchar de nuevo Continuar Reproduciendo...
- Escuchar más tarde Escuchar más tarde
Management of Bispecific Antibodies Side Effects
17 may· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Sridevi Rajeeve discusses possible side effects from bispecific antibodies, and how to manage them.
- Escuchar Escuchar de nuevo Continuar Reproduciendo...
- Escuchar más tarde Escuchar más tarde
Teclistamab, Talquetamab, and Elranatamab: Response Rates and Data
10 may· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Sridevi Rajeeve discusses the unprecedented response rates in patients treated with teclistamab, talquetamab, and elranatamab, as well as their clinical trial data.
- Escuchar Escuchar de nuevo Continuar Reproduciendo...
- Escuchar más tarde Escuchar más tarde
Efficacy of Epcoritamab and Glofitamab in Diffuse Large B-Cell Lymphoma
3 may· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Tycel Phillips examines the efficacy of two medications against diffuse large b-cell lymphoma (DLBCL)
- Escuchar Escuchar de nuevo Continuar Reproduciendo...
- Escuchar más tarde Escuchar más tarde
Barriers to Biomarker Testing: Cost and Insurance
27 abr· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Aakash Desai discusses how to address the issues of cost and insurance approval when obtaining biomarker testing.
- Escuchar Escuchar de nuevo Continuar Reproduciendo...
- Escuchar más tarde Escuchar más tarde
Barriers to Biomarker Testing: Ordering Tests
20 abr· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Aakash Desai emphasizes the importance of physicians ordering biomarker testing for patients with NSCLC
- Escuchar Escuchar de nuevo Continuar Reproduciendo...
- Escuchar más tarde Escuchar más tarde
The Adaura Trial: The Effect on EGFR+ Treatment
15 abr· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Joshua Reuss discusses the ADAURA trial, which suggested Osimertinib as treatment for EGFR+ NSCLC.
- Escuchar Escuchar de nuevo Continuar Reproduciendo...
- Escuchar más tarde Escuchar más tarde
Biomarker Driven Therapy for NSCLC
13 abr· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Aakash Desai discusses the administration of therapy for biomarkers, and how to overcome the gaps in administration, access, and affordability.
- Escuchar Escuchar de nuevo Continuar Reproduciendo...
- Escuchar más tarde Escuchar más tarde
Current Recommendations and Best Practices for Biomarker Testing
11 abr· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Aakash Desai discusses the current recommendations for biomarker testing in patients with NSCLC, as well as best practices.
- Escuchar Escuchar de nuevo Continuar Reproduciendo...
- Escuchar más tarde Escuchar más tarde
The Importance of Biomarker Testing: What is Liquid Biopsy?
9 abr· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Aakash Desai details the importance of biomarker testing, and discusses the method of liquid biopsy to do so.
- Escuchar Escuchar de nuevo Continuar Reproduciendo...
- Escuchar más tarde Escuchar más tarde
Biomarkers in NSCLC
9 abr· GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Dr. Aakash Desai gives a basic overview of biomarkers, and discusses which ones are important for patients with NSCLC.
- Escuchar Escuchar de nuevo Continuar Reproduciendo...
- Escuchar más tarde Escuchar más tarde
Mostrar más

Episodios

Advances in Thyroid Cancer Treatment

Incurable HPV Negative Head and Neck Cancer

Recurrent/Metastatic HPV Positive Head and Neck Cancer

Curable HPV Negative Head and Neck Cancer

Curable HPV Positive Head and Neck Cancer

What is a Bone Marrow Transplant?

Q&A: Do People in Rural Communities Have Equal Access to Treatment Options?

Q&A: Is my Clinical Trial Affecting my Body's Reaction to the Covid-19 Vaccine?

Bispecific Antibodies in Myeloma: Approvals and Clinical Trials

Curative Strategies for Patients with Smoldering Multiple Myeloma

Management of Bispecific Antibodies Side Effects

Efficacy of Epcoritamab and Glofitamab in Diffuse Large B-Cell Lymphoma

Barriers to Biomarker Testing: Cost and Insurance

Barriers to Biomarker Testing: Ordering Tests

The Adaura Trial: The Effect on EGFR+ Treatment

Biomarker Driven Therapy for NSCLC

Current Recommendations and Best Practices for Biomarker Testing

The Importance of Biomarker Testing: What is Liquid Biopsy?

Biomarkers in NSCLC